Drug intelligence / Profile preview

sodium chloride (Crossject)

Development stage
Unknown
Lead developer
Crossject
Modality
Small Molecules
Administration
Subcutaneous, Intramuscular
01

Overview

Zeneo NaCl is a needle-free, pre-filled, single-use auto-injector system containing a 0.9% sodium chloride solution. Developed by the French specialty pharmaceutical company Crossject, the Zeneo platform is a needle-free delivery technology that utilizes a high-pressure gas propellant to deliver medications through the skin into the subcutaneous or intramuscular tissue in less than 100 milliseconds. The sodium chloride version of the device is primarily utilized for device performance validation in clinical trials, as a reference or placebo in bioequivalence studies, and as a functional training tool for patients and healthcare providers to practice the administration technique without the use of active pharmaceutical ingredients. The Zeneo platform is also being developed for a range of emergency rescue medications, including epinephrine for anaphylaxis and midazolam for status epilepticus.

Other names
Zeneo sodium chlorideZeneo needle-free injector with sodium chloride

Beyond the preview

Go deeper on sodium chloride (Crossject).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride (Crossject).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call